Metabolic Disorders of the Brain: Part I

Seminars in Ultrasound, CT and MRI

Volumn 32, Issue 6, 2011, Pages 590-614

  Kanekar, Sangam ^a   Gustas, Cristy ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CEREBROSIDE SULFATASE; GALACTOSYLCERAMIDASE; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; PALMITOYL PROTEIN THIOESTERASE; PALMITOYL PROTEIN THIOESTERASE 1; SPHINGOLIPID; SULFATIDE; UNCLASSIFIED DRUG;

ADRENOLEUKODYSTROPHY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN DISEASE; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FABRY DISEASE; GLOBOID CELL LEUKODYSTROPHY; GM1 GANGLIOSIDOSIS; HUMAN; KEARNS SAYRE SYNDROME; LEIGH DISEASE; LIPIDOSIS; MELAS SYNDROME; MERRF SYNDROME; METABOLIC DISORDER; METACHROMATIC LEUKODYSTROPHY; MITOCHONDRIAL DNA DISORDER; MUCOPOLYSACCHARIDOSIS; NEURONAL CEROID LIPOFUSCINOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PEROXISOMAL ACYL COA OXIDASE DEFICIENCY; PEROXISOME; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REFSUM DISEASE; TAY SACHS DISEASE; ZELLWEGER SYNDROME;

BRAIN; BRAIN DISEASES, METABOLIC; DIAGNOSTIC IMAGING; HUMANS;

EID: 81855175408     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2011.08.003     Document Type: Article

References (84)

1. Becker L.E. Lysosomes peroxisomes and mitochondria: Function and disorder. AJNR Am J Neuroradiol 1992, 13:609-620.
2. Kendall B.E. Disorders of lysosomes, peroxisomes, and mitochondria. AJNR Am J Neuroradiol 1992, 13:621-653.
3. van der Knaap M.S., Valk J., de Neeling N., et al. Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 1991, 33:478-493.
4. Wraith J. Lysosomal disorders. Semin Neonatol 2002, 7:75-83.
5. Valk J., van der Knaap M.S. Lysosomes and lysosomal disorders. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders 2005, 66-73. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
6. Barkovich A.J. Toxic and metabolic brain disorders. Pediatric Neuroimaging 2005, 76-189. Raven Press, New York. (ed 4). A.J. Barkovich (Ed.).
7. Valk J., van der Knaap M.S. Globoid cell leukodystrophy (Krabbe disease). Magnetic Resonance of Myelination, and Myelin Disorders 2005, 87-95. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
8. Hagberg B., Kollberg H., Sourander P., et al. Infantile globoid cell leucodystrophy (Krabbe's disease): A clinical and genetic study of 32 Swedish cases 1953-1967. Neuropadiatrie 1969, 1:74-88.
9. Wenger D.A., Rafi M.A., Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications. Hum Mutat 1997, 10:268-279.
10. Luzi P., Rafi M.A., Wenger D.A. Characterization of the large deletion in the GALC gene found in patients with Krabbe disease. Hum Mol Genet 1995, 4:2335-2338.
11. Percy A.K., Odrezin G.T., Knowles P.D., et al. Globoid cell leukodystrophy: Comparison of neuropathology with magnetic resonance imaging. Acta Neuropathol 1994, 88:26-32.
12. Itoh M., Hayashi M., Fujioka Y., et al. Immunohistological study of globoid cell leukodystrophy. Brain Dev 2002, 24:284-290. Aug.
13. Choi S., Enzmann D.R. Infantile Krabbe disease: Complementary CT and MR findings. AJNR Am J Neuroradiol 1993, 14:1164-1166.
14. Demaerel P., Wilms G., Vendru P., et al. MR findings in globoid cell leukodystrophy. Neuroradiology 1990, 32:520-522.
15. Barone R., Brühl K., Stoeter P., et al. Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). Am J Med Genet 1996, 63:209-217.
16. Bernal O., Lenn N. Multiple cranial nerve enhancement in early infantile Krabbe's disease. Neurology 2000, 54:2348-2349.
17. Farina L., Bizzi A., Finocchiaro G., et al. Imaging and proton MR spectroscopy in adult Krabbe disease. AJNR Am J Neuroradiol 2000, 21:1478-1482.
18. Valk J., van der Knaap M.S. Metachromatic leukodystrophy. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 74-81. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
19. Faerber E.N., Melvin J., Smergel E.M. MRI appearances of metachromatic leukodystrophy. Pediatr Radiol 1999, 29:669-672.
20. Kim T.S., Kim I.O., Kim W.S., et al. MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol 1997, 18:733-738.
21. Sener N. Metachromatic leukodystrophy: Diffusion MR imaging findings. AJNR Am J Neuroradiol 2002, 23:1424-1426.
22. Valk J., van der Knaap M.S. GM1 gangliosidosis. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 96-102. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
23. Chen C.Y., Zimmerman R.A., Lee C.C., et al. Neuroimaging findings in late infantile GM1 gangliosidosis. AJNR Am J Neuroradiol 1998, 19:1628-1630.
24. Santamaria R., Chabás A., Coll M.J., et al. Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: Possible common origin for the prevalent R59H mutation among gypsies. Hum Mutat 2006, 27:1060.
25. Valk J., van der Knaap M.S. GM2 gangliosidosis. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 103-111. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
26. Myerowitz R., Lawson D., Mizukami H., et al. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 2002, 15:1343-1350.
27. Mugikura S., Takahashi S., Higano S., et al. MR findings in TaySachs disease. J Comput Assist Tomogr 1996, 20:551-555.
28. M2 gangliosidosis. AJNR Am J Neuroradiol 2005, 26:2037-2042.
29. Valk J., van der Knaap M.S. Fabry disease. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 112-118. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
30. Mitsias P., Levine S.R. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996, 40:8-17.
31. Moore D.F., Ye F., Schiffmann R., et al. Butman increased signal intensity in the pulvinar on T1-weighted images: A pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 2003, 24:1096-1101.
32. Neufeld E., Musner J. The mucopolysaccharidoses. The Metabolic and Molecular Bases on Inherited Disease 2001, 3421-3452. McGraw-Hill, New York. (ed 8). C. Scriver, A. Beudet, W. Sly (Eds.).
33. Valk J., van der Knaap M.S. Mucopolysaccharidoses. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 112-118. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
34. Barone R., Parano E., Trifiletti R.R., et al. White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: Characterization by MRI. J Neurol Sci 2002, 195:171-175.
35. Murata R., Nakajima S., Tanaka A., et al. MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol 1989, 10:1165-1170.
36. Parsons V.J., Hughes D.G., Wraith J.E. Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin Radiol 1996, 51:719-723.
37. Hughes D.G., Chadderton R.D., Cowie R.A., et al. MRI of the brain and craniocervical junction in Morquio's disease. Neuroradiology 1997, 39:381-385.
38. Kulkarni M.V., Williams J.C., Yeakley J.W., et al. Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn Reson Imaging 1987, 5:317-323.
39. Valk J., van der Knaap M.S. Ceroid neuronal lipofuscinoses. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 137-146. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
40. Dyken P., Wisniewski K. Classification of the neuronal ceroidlipofuscinoses: Expansion of the atypical form. Am J Med Genet 1995, 57:150-154.
41. Boustany R.-M. Neurology of the neuronal ceroid-lipofuscinoses: Late infantile and juvenile types. Am J Med Genet 1992, 42:533-535.
42. Autti T., Raininko R., Vanhanen S.L., et al.: MRI of neuronal ceroid-lipofuscinoses, I: Cranial MRI of 30 patients with juvenile neuronal ceroid-lipofuscinoses. Neuroradiology 1991, 38:476-482.
43. Iannetti P., Messa C., Spalice A. Positron emission tomography in neuronal ceroid lipofuscinosis (JanskyBielschowsky disease): A case report. Brain Dev 1994, 16:459-462.
44. Valk J., van der Knaap M.S. Peroxisomes and Peroxisomal disorders. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 151-153. Springer-Verlag, Berlin, Germany. (ed 3). J. Valk, M.S. van der Knaap (Eds.).
45. Moser H. Genotype-phenotype correlations in peroxisomal disorders. Dev Brain Dysfunction 1997, 10:282-292.
46. Powers J.M., Moser H.W. Peroxisomal disorders: Genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 1998, 8:101-120.
47. Martin J.J. Neuropathology of peroxisomal diseases. J Inherit Metab Dis 1995, 18(suppl 1):19-33.
48. van der Knaap M.S., Valk J. The MR spectrum of peroxisomal disorders. Neuroradiology 1991, 33:30-37.
49. Barkovich A.J., Peck W.W. MR of Zellweger syndrome. AJNR Am J Neuroradiol 1997, 18:1163-1170.
50. Stone J.A., Castillo M. MR in a patient with Zellweger syndrome presenting without cortical or myelination abnormalities. AJNR Am J Neuroradiol 1998, 19:1378-1379.
51. Choksi V., Hoeffner E., Karaarslan E., et al. Infantile Refsum disease: Case report. AJNR Am J Neuroradiol 2003, 24:2082-2084.
52. Naidu S., Moser H. Infantile Refsum disease. AJNR Am J Neuroradiol 1991, 12:1161-1163.
53. Sztriha L., Al-Gazali L.I., Wanders R.J., et al. Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency). Dev Med Child Neurol 2000, 42:492-495.
54. Williams D.W., Elster A.D., Cox T.D. Cranial MR imaging in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 1991, 12:363-365.
55. Moser H.W. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain 1997, 120:1485-1508.
56. Van der Knaap M.S., Valk J. MR of adrenoleukodystrophy: Histopathologic correlations. AJNR Am J Neuroradiol 1989, 10:S12-S14.
57. Melhem E.R., Loes D.J., Georgiades C.S., et al. X-linked adrenoleukodystrophy: The role of contrast-enhanced MR imaging in predicting disease progression. AJNR Am J Neuroradiol 2000, 21:839-844.
58. Van der Voorn J.P., Pouwels P.J., Hart A.A., et al. Childhood white matter disorders: Quantitative MR imaging and spectroscopy. Radiology 2006, 241:510-517.
59. Confort-Gouny S., Vion-Dury J., Chabrol B., et al. Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 1995, 37:568-575.
60. van der Voorn J.P., Pouwels P.J.W., Powers J.M., et al. Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 2011, 32:481-489.
61. Barkovich A.J., Ferriero D.M., Bass N., et al. Involvement of the pontomedullary corticospinal tracts: A useful finding in the diagnosis of X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 1997, 18:95-100.
62. Fournier B., Saudubray J.M., Benichou B., et al. Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy. J Clin Invest 1994, 94:526-531.
63. Poll T., Roels F., Ogier H., et al. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet 1988, 42:422-434.
64. Valk J., van der Knaap M.S. Peroxisomal acyl-CoA oxidase deficiency. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 172-175. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
65. Tulinius M.H., Holme E., Kristiansson B., et al. Mitochondrial encephalopathies in childhood: I-Biochemical and morphologic investigation. J Pediatr 1991, 119:242-250.
66. Valk J., van der Knaap M.S. Mitochondria and mitochondrial disorders. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 195-203. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
67. Holt I., Harding A., Morgan-Hughes J. Deletions of muscle mitochondria DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719.
68. DiMauro S., Moraes C.T. Mitochondrial encephalomyopathies: A review. Arch Neurol 1993, 50:1197-1208.
69. Munnich A., Rustin P., Rötig A., et al. Clinical aspects of mitochondrial disorders. J Inherit Metab Dis 1992, 15:448-455.
70. Rahman S., Blok R.B., Dahl H.H., et al. Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann Neurol 1996, 39:343-351.
71. Barkovich A.J., Good W.V., Koch T.K., et al. Mitochondrial disorders: Analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993, 14:1119-1137.
72. Medina L., Chi T.L., DeVivo D.C., et al. MR findings in patients with subacute necrotizing encephalomyelopathy (LS). AJNR Am J Neuroradiol 1990, 11:379-384.
73. Valanne L., Ketonen L., Majander A., et al. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998, 19:369-377.
74. DiMauro S., Servidei S., Zeviani M., et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987, 22:498-506.
75. Rossi A., Biancheri R., Claudio B., et al. Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. AJNR Am J Neuroradiol 2003, 24:1188-1191.
76. Valk J., van der Knaap M.S. Mitochondrial encephalopathy with lactic acidosis, and stroke-like episodes. Magnetic Resonance of Myelination, and Myelin Disorders 2005, 204-211. Springer-Verlag, Berlin, Germany. J. Valk, M.S. van der Knaap (Eds.).
77. Sue C.M., Crimmins D.S., Soo Y.S., et al. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A3243G point mutation: Implications for pathogenesis. J Neurol Neurosurg, Psychiatry 1998, 65:233-240.
78. Majoie C.B., Akkerman E.M., Blank C., et al. Mitochondrial encephalomyopathy: Comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging-Case report. AJNR Am J Neuroradiol 2002, 23:813-816.
79. Sakuta R., Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989, 25:594-601.
80. Liu Z., Zheng D., Wang X., et al. Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy. AJNR Am J Neuroradiol 2011, 32:898-902.
81. Castillo M., Kwock L., Green C. MELAS syndrome: Imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995, 16:233-239.
82. Ito S., Shirai W., Asahina M., et al. Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. AJNR Am J Neuroradiol 2008, 29:392-395.
83. Anan R., Nakagawa M., Miyata M., et al. Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995, 91:955-961.
84. Chu B.C., Terae S., Takahashi C., et al. MRI of the brain in the KearnsSayre syndrome: Report of four cases and a review. Neuroradiology 1999, 41:759-764.